pemafibrate
Kowa Pharmaceuticals
['cardio']
#prominent trial main results. pemafibrate did not reduce major cardiovascular outcomes, no benefit in any subgroup. #aha22 thread 4/5 
Johns Hopkins Medicine. Associate Professor, Cardiology. Co-Editor in Chief @AJPCardio. #WomenHeartHealth #CardioObstetrics #cvPrev #echofirst She/her #BeKind